Replies to post #82169 on Biotech Values

[DewDiligence]

This MATK news is pretty interesting, and I wouldn’t be surprised if the deal with BP was prompted by XOM’s recent high-profile algae deal with Craig Venter: #msg-39551386.

When XOM (the world’s largest corporation) gets involved in a new technology, the technology goes from “fringe” to “mainstream” in one fell swoop, and this seems to be what happened here.

[DewDiligence]

Royal DSM acquires MATK for $31.50/sh in cash, a 35% premium to Monday’s closing price:

http://finance.yahoo.com/news/DSM-to-Acquire-Martek-to-Add-prnews-3207228334.html?x=0&.v=1

CC at 3:30am ET (9:30am local time).